Real-world data (RWD) offers the possibility of providing important information to help inform regulatory decision-making. But turning this…

Writing in the DIA Global Forum’s special November 2022 issue on the Digital Virtuous Loop Karin Van Baelen and Susan Sandler – both of Janssen…

One of the enduring conundrums around ground-breaking and potentially paradigm-shifting treatments such as CAR-T is the ever-thorny question of how…

Emerging cell and gene therapies herald immense clinical value for patients, society, and healthcare systems: carrying the potential to offer…

Anette Margrethe Storstein MD PhD of the Norwegian Brain Council introduces the burden of neurodegenerative disease in Norway today, the ongoing…

Norway, more well-known internationally as an innovation hub for oil & gas and marine biology, is attempting to reverse the trend of reducing…

Ole Alexander Opdalshei introduces the role of the Norwegian Cancer Society within Norwegian cancer research, care services and information…

Nigel Hughes of the European Health Data & Evidence Network (EHDEN) outlines EHDEN's scope and purpose and highlights why greater collaboration on…

Ulrich Neumann of Certara outlines recent developments in the use of real-world evidence (RWE) and the sizeable impact it stands to make on the global…

Holmusk’s Nawal Roy highlights the increasing recognition of the value of real-world evidence (RWE) by both innovative pharma companies and drug…